A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy: Study design and patient characteristics
Ray Bain, Richard Rohde, Lawrence G. Hunsicker, Janet McGill, Sidney Kobrin, Edmund J. Lewis, John Lachin, Jay Wish, John Sheehan, Marc Pohl, Tomas Berl, Godofredo Santiago, Jacob Lemann, Samuel Blumenthal, Lee Hebert, Norris Stanley Nahman, Stanley Goldfarb, Mohammad Sikder, Roger Rodby, Andrew LeveyMark Williams, Frederick Whittier, Daniel Cattran, Stephen Lietz, Daiva Valaitis, Jesse Hano, Douglas Maxwell, Jerome Porush, Samuel Spitalewitz, Kenneth Shapiro, Sharon Adler, Nathan Tolchin, Wendy Hoy, Robert Bernstein, Laura Svetkey, Zeev Sharon, Peter Lodewick, Hugh Tildesley, Nadir Farid, Julia Breyer
Dive into the research topics of 'A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy: Study design and patient characteristics'. Together they form a unique fingerprint.